Americans now say they approve of free trade by 64%-27%, a margin of better than two to one. That's up from 57%-37% early in Trump's presidency, and 51%-41% near the end of...Politicsread more
The yield on the benchmark 10-year Treasury note briefly fell below the 2-year rate on Wednesday, a phenomenon in the bond market known as yield curve inversion, which is...Marketsread more
The MacBook Pro recall and its subsequent ban from flights underscores the increasing brand risk from problems with lithium-ion batteries.Technologyread more
Experts say the timing of Amazon executives' contributions to Rep. David Cicilline likely reflect the company's heightened urgency over growing regulatory scrutiny.Technologyread more
CNBC combed through Wall Street research to see which stocks are still a buy after their earnings reports.Marketsread more
Despite aggressive strides, Waymo needs one thing before their self-driving cars become a seriously useful transportation system: people. We talked to the ones closest to it.Technologyread more
Coinbase security chief Philip Martin explains, "Possession of a key is possession of your currency. What that means is that you can't revoke a cryptocurrency key, if that key...Technologyread more
Fraud investigator Harry Markopolos' accusations extended beyond GE's management to actuaries, auditors and analysts who he claims overlooked billions in liabilities.Marketsread more
The Supreme Court could strike down the constitutionality of the Consumer Financial Protection Bureau, an agency Elizabeth Warren has likened to her child and which Justice...2020 Electionsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
The company's S-1 lays the groundwork for what is widely expected to be one of the largest initial public offerings of the year, second only to Uber's IPO in May. It's also...Technologyread more
China’s drug control agency on Monday said the United States should do more to cut its demand for opioids to tackle the use of synthetic drug fentanyl, but it vowed to step up cooperation after Chinese production of the substance had been blamed for fueling the U.S. opioid crisis.
U.S. President Donald Trump said in November on a state visit to Beijing that China and the United States would do more to stem what he called a “flood of cheap and deadly” fentanyl “manufactured in China” from entering the United States.
A year-long congressional probe into the use of fentanyl in the United States found that the substance could easily be bought online from Chinese “labs” and mailed to the United States due to gaps in oversight in the U.S. Postal Service.
“China’s drug control agencies, now and in the years to come, will place greater emphasis on drug control cooperation between China and the United States,” Liu Yuejin, deputy head of China’s National Narcotics Commission, told a news conference.
“But I believe that to resolve this the more important issue is for the United States to strive to reduce and compress the great demand and drug consumption markets of opioids,” he said.
While China accepts that some new psychoactive substances, including fentanyl, manufactured in China are sold in the United States, the substances are not yet readily abused and trafficked in China itself, he said.
Asked whether joint efforts between China and United States would be impacted by current tensions in the bilateral relationship, Liu said that political factors would not affect China’s resolve to combat drug manufacture and trafficking.
According to the U.S. Centers for Disease Control and Prevention, opioids were responsible for more than 33,000 U.S. deaths in 2015. Fentanyl is 50 times more potent than heroin and 100 times more potent than morphine.
Beijing has taken steps to crack down on the production and export of synthetic drugs, and has placed fentanyl and 22 other related compounds on its list of controlled substances.